These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9088539)

  • 1. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC; Schiller PW
    Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid diketopiperazines: synthesis and activity of a prototypic class of opioid antagonists.
    Balboni G; Guerrini R; Salvadori S; Tomatis R; Bryant SD; Bianchi C; Attila M; Lazarus LH
    Biol Chem; 1997 Jan; 378(1):19-29. PubMed ID: 9049061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC; Schiller PW
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
    Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
    Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW
    Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
    J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity of new mu and delta opioid peptides.
    Capasso A
    Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures.
    Flippen-Anderson JL; Deschamps JR; George C; Reddy PA; Lewin AH; Brine GA; Sheldrick G; Nikiforovich G
    J Pept Res; 1997 May; 49(5):384-93. PubMed ID: 9211219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
    Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
    FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist.
    Lovekamp T; Cooper PS; Hardison J; Bryant SD; Guerrini R; Balboni G; Salvadori S; Lazarus LH
    Brain Res; 2001 May; 902(1):131-4. PubMed ID: 11376603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
    Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
    J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
    Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.
    Ciajolo MR; Balboni G; Picone D; Salvadori S; Tancredi T; Temussi PA; Tuzi A
    Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
    Tryoen-Tóth P; Décaillot FM; Filliol D; Befort K; Lazarus LH; Schiller PW; Schmidhammer H; Kieffer BL
    J Pharmacol Exp Ther; 2005 Apr; 313(1):410-21. PubMed ID: 15590769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
    Su YF; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.